Barcoded Rational AAV Vector Evolution enables systematic in vivo mapping of peptide binding motifs
Marcus DavidssoniD, Gang WangiD, Patrick Aldrin-KirkiD, Tiago CardosoiD, Sara NolbrantiD, Morgan HartnoriD, Janitha M. MudannayakeiD, Malin ParmariD, Tomas BjörklundiD
Abstract
Engineering of Adeno-associated viral (AAV) vector capsids through directed evolution has been used to generate novel capsids with altered tropism and function1-9. This approach, however, involves a selection process that requires multiple generations of screenings to identify real functional capsids2-4. Due to the random nature of this process, it is also inherently unreproducible, and the resulting capsid variants provide little mechanistic insights into the molecular targets engaged. To overcome this, we have developed a novel method for rational capsid evolution named Barcoded Rational AAV Vector Evolution (BRAVE). The key to this method is a novel viral production approach where each virus particle displays a protein-derived peptide on the surface which is linked to a unique barcode in the packaged genome10. Through hidden Markov model-based clustering11, we were able to identify novel consensus motifs for cell-type specific retrograde transport in neurons in vivo in the brain. The BRAVE approach enables the selection of novel capsid structures using only a single-generation screening. Furthermore, it can be used to map, with high resolution, the putative binding sequences of large protein libraries.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 142
- FWCI
- 12.20
- Field percentile
- top 1%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- EvoPRAISE: computationally guided directed evolution for rational AAV capsid engineering
Hiroaki Ono, Shoko Fujino, Genshiro A. Sunagawa·bioRxiv·Nov 2, 2025
- Administration of barcoded AAV capsid library to the putamen of non-human primates identifies variants with efficient retrograde transport
Yulia Dzhashiashvili, Jodi L. McBride, … Tomas Björklund·Molecular TherapyPeer-reviewed·Dec 10, 2025
- Structural basis of liver de-targeting and neuronal tropism of CNS-targeted AAV capsids
Tyler J. Brittain, Seongmin Jang, … Viviana Gradinaru·Molecular TherapyPeer-reviewed·Mar 28, 2026
- Targeting AAV vectors to the CNS via de novo engineered capsid-receptor interactions
Qin Huang, Albert Tian Chen, … Benjamin E. Deverman·bioRxiv·Oct 31, 2022
- Engineered AAV Capsids with Enhanced Extracellular Vesicle Loading via Rational Design and Directed Evolution
Ioulia Vorobieva, Marina Luchner, … Dhanu Gupta·bioRxiv·Dec 13, 2025
- VCAP-102 Achieves Exceptional BBB Penetration in Marmosets After Ten Years of AAV Capsid Evaluation
Yasunori Matsuzaki, Ayumu Konno, … Hirokazu Hirai·bioRxiv·Dec 9, 2025